Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
19 December 2023 - 9:19AM
Edgar (US Regulatory)
|
|
OMB
APPROVAL |
|
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
OMB
Number: |
3235-0058 |
Expires: |
April
30, 2025 |
Estimated
average burden hours per response. |
2.50 |
|
FORM
12b-25 |
SEC
FILE NUMBER |
333-108715 |
|
|
CUSIP
NUMBER |
|
NOTIFICATION
OF LATE FILING |
481159101 |
(Check
one): |
☐
Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN
☐
Form N-CSR |
|
|
|
For
Period Ended: October 31, 2023
☐
Transition Report on Form 10-K
☐
Transition Report on Form 20-F
☐
Transition Report on Form 11-K
☐
Transition Report on Form 10-Q
For
the Transition Period Ended: ____________________ |
Read
Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART
I — REGISTRANT INFORMATION
IDAHO
COPPER CORPORATION |
Full
Name of Registrant |
|
F/K/A
JOWAY HEALTH INDUSTRIES GROUP |
Former
Name if Applicable |
|
800
W. MAIN ST., STE 1460 |
Address
of Principal Executive Office (Street and Number) |
|
BOISE,
ID 83702 |
City,
State and Zip Code |
PART
II — RULES 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed. (Check box if appropriate)
☒ |
|
(a) |
The
reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
|
(b) |
The
subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion
thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report
or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the
fifth calendar day following the prescribed due date; and |
|
(c) |
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
SEC
1344 (06-19) |
Persons
who are to respond to the collection of information contained in this form are not required to respond un1ess the form displays a
currently valid OMB control number. |
|
PART
III — NARRATIVE
State
below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not
be filed within the prescribed time period.
(Attach extra Sheets if Needed)
PART
IV — OTHER INFORMATION
(1) |
Name
and telephone number of person to contact in regard to this notification |
|
|
ROBERT SCANNELL |
|
415 |
|
370-9209 |
|
(Name) |
|
(Area
Code) |
|
(Telephone
Number) |
|
(2) |
Have
all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s)
been filed? If answer is no, identify report(s). |
|
|
Yes
☒ NO ☐ |
|
|
|
|
(3) |
Is
it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will
be reflected by the earnings statements to be included in the subject report or portion thereof? |
|
|
Yes
☐ NO ☒ |
|
|
If
so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made. |
IDAHO
COPPER CORPORATION
(Name of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date: |
DECEMBER 15, 2023 |
|
By: |
/s/ ROBERT
SCANNELL |
INSTRUCTION:
The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of
the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by
an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of
the registrant shall be filed with the form.
ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).
NARRATIVE
FOR SEC FORM 12b-25
IDAHO
COPPER CORPORATION
SEC
FILE# 333-108715
CUSIP
# 481191019
DATE:
DECEMBER 18, 2023
The
registrant's auditor raised an 11th-hour accounting issue that required additional research and consideration. The auditor was therefore
unable to complete the financial statements, and management was unable to complete the Management Discussion and Analysis, prior to the
filing deadline. The issue in question is not expected to materially impact the registrant's financial statements.
Joway Health Industries (PK) (USOTC:GTVI)
Historical Stock Chart
From May 2024 to Jun 2024
Joway Health Industries (PK) (USOTC:GTVI)
Historical Stock Chart
From Jun 2023 to Jun 2024